Investor · New York, NY

Dane F. Lund

Open Dane in the network graph →

Filings

11

SEC Form D

Connections

47

co-filers

Capital

$20.4M

across filings

Active

May 2020

to Apr 2022

Most-connected co-filers (47)

Michael F. Peng · New York, NY9 shared Dion F. Chu · New York, NY9 shared Kara Forney · Albuquerque, NM8 shared Robert Ruffolo · Monmouth Junction, NJ6 shared Robert Essner · Monmouth Junction, NJ6 shared Ulrich Wiesner · Monmouth Junction, NJ6 shared Geno Germano · Monmouth Junction, NJ6 shared Tim Boris · Monmouth Junction, NJ6 shared Jan F. Van Eck · New York, NY6 shared Teresa Ressel · Monmouth Junction, NJ6 shared Jonathan J. Simon · New York, NY6 shared Michael Smith · Monmouth Junction, NJ6 shared Helene Servillon · Dover, DE6 shared Spencer Patterson · Orem, UT6 shared Ralph Yarro · Orem, UT6 shared Michael Wolfgramm · Orem, UT6 shared John M. Courtright · Elmhurst, IL6 shared Ayman M. Shahin · Dubai, C06 shared David Anthony · Broomfield, CO6 shared Janice Craig · Vancouver, British Columbia, Canada6 shared Victor D. Woolridge · New York, NY4 shared Kasper Bihlet · Houston, TX4 shared Jakub Rehor · Reno, NV4 shared Josh Froelich · Houston, TX4 shared

Recent filings (11)

Orthogonal SPAC Advantage Fund, LPApr 2022 · 12 co-filers Orthogonal SPAC Advantage Fund, LPMay 2021 · 12 co-filers Orthogonal SPAC Advantage Fund, LPApr 2021 · 9 co-filers Orthogonal SPAC Advantage Fund, LPApr 2021 · 9 co-filers Elucida Oncology, Inc.Jan 2021 · 29 co-filers$35.0M Elucida Oncology, Inc.Dec 2020 · 29 co-filers$35.0M Elucida Oncology, Inc.Dec 2020 · 29 co-filers$35.0M Elucida Oncology, Inc.Nov 2020 · 29 co-filers$35.0M Elucida Oncology, Inc.Jun 2020 · 20 co-filers$30.0M Feals, Inc.Jun 2020 · 8 co-filers$2.0M Feals, Inc.Jun 2020 · 10 co-filers$2.0M Elucida Oncology, Inc.May 2020 · 20 co-filers$30.0M

Derived from public SEC Form D (Reg D) filings; entities resolved probabilistically. See Dane in the interactive graph →